Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices.

Aged Female Heart-Assist Devices / standards Humans Male Middle Aged Platelet Activation / physiology Platelet Aggregation / physiology Prospective Studies
HVAD HeartMate 3 LVAD platelet activation platelet aggregation

Journal

Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117

Informations de publication

Date de publication:
17 Feb 2022
Historique:
pubmed: 25 3 2021
medline: 30 3 2022
entrez: 24 3 2021
Statut: ppublish

Résumé

Left-ventricular assist devices (LVADs) improve outcomes in end-stage heart failure patients. Two centrifugal-flow LVAD systems are currently approved, HeartMate 3 (HM3) and Medtronic/Heartware HVAD (HVAD). Clinical findings suggest differences in thrombogenicity between both systems. We compared markers of platelet activation and aggregation between HM3 and HVAD. We prospectively included 59 LVAD patients (40 HM3, 19 HVAD). Platelet

Identifiants

DOI: 10.1080/09537104.2021.1881950 PMID: 33760697
pubmed: 33760697
doi: 10.1080/09537104.2021.1881950
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-256

Auteurs

Maximilian Tscharre (M)

Department of Internal Medicine, Cardiology and Nephrology, Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria.
Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
ORCID: 0000-0002-9265-628X

Franziska Wittmann (F)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Daniela Kitzmantl (D)

Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Silvia Lee (S)

Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Beate Eichelberger (B)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

Patricia P Wadowski (PP)

Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Günther Laufer (G)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Dominik Wiedemann (D)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Birgit Forstner-Bergauer (B)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Cihan Ay (C)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Simon Panzer (S)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

Daniel Zimpfer (D)

Department of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Thomas Gremmel (T)

Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Department of Internal Medicine I, Cardiology and Intensive Care Medicine, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.
ORCID: 0000-0001-9554-7292

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Platelet activation and aggregation in...
questionsmedicales.fr › Équipement et fournitures › Équipement chirurgical › Organes artificiels › Coeur artificiel › Dispositifs d'assistance circulatoire › Platelet activation and aggregation in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Platelet activation and aggregation in...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Platelet activation and aggregation in...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémostase › Activation plaquettaire › Platelet activation and aggregation in...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémostase › Activation plaquettaire › Agrégation plaquettaire › Platelet activation and aggregation in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Platelet activation and aggregation in...